Market Overview:
Bioactive peptides are short chains of amino acids that exert physiological effects once ingested. They are increasingly being added to functional foods and dietary supplements due to their therapeutic properties including antioxidative, antihypertensive, immunomodulatory and other health benefits. The growing demand for nutraceuticals and functional foods has led to a rise in the demand for bioactive peptides in the market.
Market key trends:
One of the key trends driving the growth of the bioactive peptide market is the multi-functionality offered by these peptides. Bioactive peptides can have anti-obesity, antimicrobial, antioxidant, anti-hypertensive, mineral binding, opioid and ACE-inhibitor properties. They can also help improve cardiovascular health, boost immunity, enhance bone health and promote weight management. The diverse range of physiological effects offered by individual peptides is fueling their widespread adoption in the food and beverage industry. The development of novel peptides with multi-target activities through extensive research efforts is further expected to support the market growth over the forecast period.
Porter's Analysis
Threat of new entrants: The threat of new entrants in the bioactive peptide market is low owing to high capital requirements and the presence of established players. However, few small players are emerging with innovative products
Bargaining power of buyers: The bargaining power of buyers is high due to the availability of various products from different manufacturers. Buyers can negotiate on prices and demand customized products as per their requirements.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw material suppliers have limited control over pricing. Suppliers prefer dealing with large players for stable demand.
Threat of new substitutes: The threat of new substitutes is low in the bioactive peptide market as no close substitute is available currently that can provide similar health benefits.
Competitive rivalry: Intense competition exists among the key players to gain major market share.
The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: The bioactive peptides market is growing at a rapid pace owing to the multiple health benefits of peptides. Also, the rising demand for nutraceuticals and functional foods supplements the market growth.
Weakness: High costs associated with R&D and clinical trials. Peptide instability during processing and storage acts as a constraint.
Opportunity: Growing demand for clean label and natural ingredients in food products and expanding applications of peptides in cosmetic and personal care industries provide lucrative opportunities.
Threats: Stringent regulatory approval process for new products and compatibility issues during formulation development are major threats.
Key Takeaways
The global bioactive peptide market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing demand for functional foods & beverages. North America dominated the global market in 2020 owing to rising health consciousness among consumers and a growing preference for dietary supplements. Europe is the second largest and fastest growing regional market due to increasing spending on healthcare and fitness. Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, visited, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.
